blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1906936

EP1906936 - FORMULATIONS CONTAINING LOSARTAN AND/OR ITS SALTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.01.2011
Database last updated on 22.08.2024
Most recent event   Tooltip28.01.2011Application deemed to be withdrawnpublished on 02.03.2011  [2011/09]
Applicant(s)For all designated states
Combino Pharm, S.L.
Fructuós Gelabert, 6-8
08970 Saint Joan Despi / ES
[2008/15]
Inventor(s)01 / LLORET PEREZ, Sergio
Coroleu, 22, Esc. A, 2 ,1a
E-08030 Barcelona / ES
 [2008/15]
Representative(s)Duncan, Garreth Andrew, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2008/15]Duncan, Garreth Andrew, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Application number, filing date06821014.517.05.2006
[2008/15]
WO2006IB03440
Priority number, dateUS20050681961P18.05.2005         Original published format: US 681961 P
[2008/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007026261
Date:08.03.2007
Language:EN
[2007/10]
Type: A2 Application without search report 
No.:EP1906936
Date:09.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2007 takes the place of the publication of the European patent application.
[2008/15]
Search report(s)International search report - published on:EP03.01.2008
ClassificationIPC:A61K9/20, A61K9/28, A61K31/41, A61K31/4178
[2008/15]
CPC:
A61K9/2054 (EP,US); A61K31/41 (EP,US); A61K31/4178 (EP,US);
A61K9/2018 (EP,US); A61K9/2059 (EP,US); A61K9/2866 (EP,US);
A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/15]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:FORMULIERUNGEN MIT LOSARTAN UND/ODER DESSEN SALZEN[2008/15]
English:FORMULATIONS CONTAINING LOSARTAN AND/OR ITS SALTS[2008/15]
French:PREPARATIONS CONTENANT DU LOSARTAN ET/OU DES SELS DE CE COMPOSE[2008/15]
Entry into regional phase19.12.2007National basic fee paid 
19.12.2007Designation fee(s) paid 
19.12.2007Examination fee paid 
Examination procedure19.12.2007Examination requested  [2008/15]
28.05.2008Despatch of a communication from the examining division (Time limit: M06)
28.11.2008Reply to a communication from the examining division
29.03.2010Communication of intention to grant the patent
10.08.2010Application deemed to be withdrawn, date of legal effect  [2011/09]
27.09.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2011/09]
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the filing fee
14.02.2008Request for further processing filed
14.02.2008Full payment received (date of receipt of payment)
Request granted
28.02.2008Decision despatched
Fees paidRenewal fee
18.03.2008Renewal fee patent year 03
07.05.2009Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.05.201005   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2004017896  (MERCK & CO INC [US], et al) [X] 11 * page 19, lines 14-34 * * page 26, lines 6-18 * [I] 1-10,12,13;
 [XI]EP0511767  (MERCK & CO INC [US]) [X] 11,13 * page 3, line 47 - page 4, line 2 * * examples 1,2 * [I] 12;
 [X]WO9749392  (MERCK & CO INC [US], et al) [X] 11-13 * pages 9-13 *;
 [XI]WO2004066997  (LEK PHARMACEUTICALS [SI], et al) [X] 11,12 * page 29, paragraph 3 * * page 31, paragraphs 2-4 * * pages 44-45; tables 4,5 * * pages 66-68; examples 50,51 * [I] 13;
 [PI]  - MADAN ET AL, "PHARMACEUTICAL COMPOSITION COMPRISING ATORVASTATIN AND LOSARTAN", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, (20061214), ISSN 1533-0001, XP013117222 [PI] 1-6,11-13 * pages 9-11; example . *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.